In SLE, IFNα protein associated with disease activity and predicted the duration of remission [21], but protein levels of IFNα have previously neither been reliably measured in RA nor related to clinical characteristics or treatment effect. The gene discussed is IFNA1; the disease is systemic lupus erythematosus.